A shorter plasma half life does not predict less drug accumulation
Sebaldt, R.J.
Journal of Rheumatology 13(6): 1185-1186
1986
ISSN/ISBN: 0315-162X PMID: 3560108 Document Number: 282874
Document emailed within 1 workday
Related Documents
Graziottin, A. 2016: The shorter, the better: a review of the evidence for a shorter contraceptive hormone-free interval European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 21(2): 93-105Ilett, E.E.; Boysen, T. 2014: HIV-positive individuals still have shorter life-expectancy than the general population Ugeskrift for Laeger 176(3): 253-257
Hu, X.; Chen, W.Y. 1994: Restoration of intracellular drug accumulation in MDR cell line K562r does not mean reversal of its drug resistance Zhongguo Yao Li Xue Bao 15(5): 422-426
Grigsby, T.J.; Forster, M.; Baezconde-Garbanati, L.; Soto, D.W.; Unger, J.B. 2014: Do adolescent drug use consequences predict externalizing and internalizing problems in emerging adulthood as well as traditional drug use measures in a Hispanic sample? Addictive Behaviors 39(3): 644-651
Hu, X.; Pan, Q.; Zheng, S. 1995: Reduced intracellular drug accumulation related to overexpression of P-glycoprotein cannot explain the complete drug resistance in MDR cell variant K562/Dox Zhonghua Zhong Liu Za Zhi 17(2): 85-88
Ho Ngoc-Ta Trung, A.; Sirois, G. 1987: Influence of plasma pH on quinidine uptake by erythrocytes: estimation of free drug fraction in plasma from blood/and erythrocyte/plasma concentration ratios Pharmaceutica Acta Helvetiae 62(2): 61-64
Keizer, H.G.; Schuurhuis, G.J.; Broxterman, H.J.; Lankelma, J.; Schoonen, W.G.; van Rijn, J.; Pinedo, H.M.; Joenje, H. 1989: Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells Cancer Research 49(11): 2988-2993
Leonetti, G.; Bianchini, C.; Picotti, G.B.; Cesura, A.; Caccamo, L.; Marini, A. 1980: Plasma catecholamines and plasma renin activity at birth and during the first days of life Clinical Science 59 Suppl 6(153): 319s-321s
Adam, G.I. 2001: The development of pharmacogenomic models to predict drug response Current Opinion in Drug Discovery and Development 4(3): 296-300
Shapiro, M.; Lee, B.E.; Rutledge, J.R.; Korst, R.J. 2018: The use of Standardized Measures to Predict and Assess Quality of Life after Laparoscopic Hiatal Hernia Repair American Surgeon 84(6): 789-795
Völzke, H.; Robinson, D.M.; Kleine, V.; Hertwig, S.; Schwahn, C.; Grimm, R.; Eckel, L.; Rettig, R. 2003: Preoperative plasma fibrinogen levels predict mortality after coronary artery bypass grafting Thrombosis and Haemostasis 89(5): 885-891
Bunupuradah, T.; Kosalaraksa, P.; Vibol, U.; Hansudewechakul, R.; Sophonphan, J.; Kanjanavanit, S.; Ngampiyaskul, C.; Wongsawat, J.; Luesomboon, W.; Vonthanak, S.; Ananworanich, J.; Ruxrungtham, K.; Puthanakit, T.; Phanuphak, P.; Cooper, D.A.; Kaldor, J.; Vun, M.C.; Vonthanak, S.; Ruxrungtham, K.; Giaquinto, C.; Cotton, M.; Lolekha, R.; Sirisanthana, V.; Chokephaibulkit, K.; Suntarattiwong, P.; Volberding, P.; Bangdiwala, S.; Lim, K.; Samuel, N.M.; Schoenfeld, D.; Sohn, A.H.; Solomon, S.; Suwangool, P.; Wang, R.; Zhang, F.; Zoloth, L.; Dixon, D.O.; Fox, L.; Ojumu, A.O.; Bupp, J.E.; Ussery, M.; Wetherall, N.T.; Brouwers, P.; Mofenson, L.M.; Douoguih, M.; Law, M.; Shearer, W.T.; Valcour, V.; Paul, R.; Pattanapanyasat, K.; Sakulploy, N.; McNic 2013: Impact of antiretroviral therapy on quality of life in HIV-infected Southeast Asian children in the PREDICT study Aids Patient Care and Stds 27(11): 596-603
Indrebø, K.Lerum.; Natvig, G.Karin.; Andersen, J.Roger. 2016: A Cross-sectional Study to Determine Whether Adjustment to an Ostomy Can Predict Health-related and/or Overall Quality of Life Ostomy/Wound Management 62(10): 50-59
Kurz, H. 1977: Drug accumulation and dose finding (authors' transl) Arzneimittel-Forschung 27(2a): 250-253
Borrelli, E.; Roux-Lombard, P.; Grau, G.E.; Girardin, E.; Ricou, B.; Dayer, J.; Suter, P.M. 1996: Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk Critical Care Medicine 24(3): 392-397
Price, P.; Haddow, L.J.; Affandi, J.; Agarwal, U.; Easterbrook, P.J.; Elliott, J.; French, M.; Kumar, M.; Moosa, M-Yunus.S.; Oliver, B.; Singh, S.; Sola, M.; Saphonn, V.; Vun, M.Chhi. 2012: Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with Mycobacterium tuberculosis Aids Research and Human Retroviruses 28(10): 1216-1219
Dettli, L. 1976: Prediction of drug elimination in renal disease based on drug concentration measurements in plasma and/or urine Arzneimittel-Forschung 26(6): 1254
Vahlquist, A.; Rollman, O.; Pihl-Lundin, I. 1986: Tissue distribution of aromatic retinoid (etretinate) in three autopsy cases: drug accumulation in adrenals and fat Acta Dermato-Venereologica 66(5): 431-434
De Maat, M.P.M.; Madsen, J.S.; Langdahl, B.; Bladbjerg, E.M.; Tofteng, C.L.; Abrahamsen, B.; Rejnmark, L.; Brixen, K.; Christensen, K.; Jespersen, J.ør.; Kristensen, S.ør.R. 2007: Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy Thrombosis and Haemostasis 97(2): 234-239
Houghton, J.A.; Meyer, W.H.; Houghton, P.J. 1987: Scheduling of vincristine: drug accumulation and response of xenografts of childhood rhabdomyosarcoma determined by frequency of administration Cancer Treatment Reports 71(7-8): 717-721